Randomized controlled clinical trial of the impact of combined application of rhamnosus probiotics and oral nystatin on the colonization of intestinal Candida albicans in low birth weight neonates <2,500 grams
The concurrent use of Rhamnosus probiotics and oral Nystatin can lead to a reduction of positive <i>C. albicans</i> stool culture results, average time for certain variables such as the onset of nutrition, time to reach 100 ml/kg of milk intake per day, NPO days, total NPO time during hospitalization, episodes of intolerance until discharge, and duration of hospitalization in infants weighing <2,500 grams. Hence, their simultaneous administration is recommended for these neonates.
Authors
- Mazyar Vakiliamini (ORCID: https://orcid.org/0000-0002-9677-3846)
- R Chegenelorestani
- Hajar Motamed (ORCID: https://orcid.org/0000-0002-4419-0497)
- Majid Rezaei (ORCID: https://orcid.org/0000-0002-7755-7179)
- Mosayeb Rostamian (ORCID: https://orcid.org/0000-0002-1071-7019)
- Samira Zarei
- Pourya Mohammadi (ORCID: https://orcid.org/0000-0002-9715-1811)
- Reza Habibi
- Farzad Mashreghi
- Fatemeh Rezaeeniya
Institutions
- Lorestan University of Medical Sciences (IR)
- Kermanshah University of Medical Sciences (IR)
- Tabaran Institute of Higher Education (IR)
- Bushehr University of Medical Sciences (IR)
- Qazvin University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2026-02-25
- DOI
- https://doi.org/10.3205/dgkh000632
- Primary Topic
- Probiotics and Fermented Foods
- Type
- article
- Field-Weighted Citation Impact
- 0.00